XClose

UCL Division of Surgery and Interventional Science

Home
Menu

2018 Publications

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
V. Kasivisvanathan, A.S. Rannikko, M. Borghi, V. Panebianco, L.A. Mynderse, M.H. Vaarala, A. Briganti, L. Budäus, G. Hellawell, R.G. Hindley, M.J. Roobol, S. Eggener, M. Ghei, A. Villers, F. Bladou, G.M. Villeirs, J. Virdi, S. Boxler, G. Robert, P.B. Singh, W. Venderink, B.A. Hadaschik, A. Ruffion, J.C. Hu, D. Margolis, S. Crouzet, L. Klotz, S.S. Taneja, P. Pinto, I. Gill, C. Allen, F. Giganti, A. Freeman, S. Morris, S. Punwani, N.R. Williams, C. Brew-Graves, J. Deeks, Y. Takwoingi, M. Emberton, and C.M. Moore, for the PRECISION Study Group Collaborators (2018):'MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis' The New England Journal of Medicine, doi: 10.1056/NEJMoa1801993

 

issuu Widget Placeholder33644033/62036842

 
Prostate radiofrequency ablation focal treatment (proRAFT): Results of a prospective development study for localised prostate cancer.
Orczyk C, Brew-graves C, WIlliams N, Potyka I, Ramachandran N, Freeman A, Emberton M, Ahmed HU (2018). PROSTATE RADIOFREQUENCY ABLATION FOCAL TREATMENT (PRORAFT): RESULTS OF A PROSPECTIVE DEVELOPMENT STUDY FOR LOCALISED PROSTATE CANCER. Presented at: American-Urological-Association(AUA) Annual Meeting

issuu Widget Placeholder33644033/65743629

 
The CADMUS trial ‐ Multi‐parametric ultrasound targeted biopsies compared to multi‐parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer
Grey A, Scott R, Charman S, van der Meulen J, Frinking P, Acher P, Liyanage S, Madaan S,Constantinescu G, Shah B, Graves CB, Freeman A, Jameson C, Ramachandran N, Emberton M, Arya M, Ahmed HU (2018) The CADMUS trial ‐ Multi‐parametric ultrasound targeted biopsies compared to multi‐parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer. Contemp Clin Trials. DOI: http://dx.doi.org/10.1016/j.cct.2017

issuu Widget Placeholder33644033/65743789